Wednesday, July 1, 2015 Daily Archives
Your Shake Flask is Not a Black Box Anymore! Online Measurements of Metabolic Activity to Accelerate your Bioprocess Development (Video)
Case Study of 12 Flexible Facility Biopharm Projects: Emerging Trends in Flexibility for Strategic Advantage (Video)
Reducing the Risk Associated with the Filling of Biologics with Advanced Aseptic Processing (Video)
EMD Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service. With this addition, the Company now provides a full range of services for optimizing yield, productivity, consistency and efficiency of clinical scale drug products. The new Clone Generation Service includes expression of recombinant proteins such as hormones, growth factors and mono- and bi-specific monoclonal antibodies. Customers can choose from DG44 and CHO-S cell lines,…
EMD Millipore Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use
EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, Germany, today introduced the Mobius® 2000 liter single-use bioreactor. The 2000 liter bioreactor joins the Mobius® stirred tank bioreactor portfolio (from 3 to 2000 liters) that provides the ultimate in flexibility, scalability, and convenience. With configurable software, hardware, and single-use Flexware® assemblies for suspension and adherent cell culture applications, the new 2000 liter single-use bioreactor incorporates industry-leading design features that enable users to easily optimize their upstream process. The…